Introduction: As per the WHO reports dated July 7, 2021, 184,324,026 confirmed cases of COVID-19 were found in the world and 196,894 cases were found in Libya. Healthcare workers (HCWs), pharmacists, in particular, have been affected a lot because of COVID-19. Community pharmacies are considered workplaces with elevated exposure risk to COVID-19. Method: This study aims to roughly estimate the risk of COVID-19 exposure among pharmacists and pharmacy assistants working in pharmacies in Libya. An anonymous cross-sectional online survey was conducted among pharmacists and pharmacy assistants working in hospital pharmacies and community pharmacies. Between November 11th, 2020 and January 7th, 2021, a Google Form questionnaire was delivered through social media and instant messaging platforms, to certified community pharmacists and pharmacy assistants residing in Libya. Results: Out of 207 respondents, the majority (72.4%) reported having at least one or more flu-like symptoms. In addition, 52.17% of them reported that one of their relatives had at least one or more flu-like symptoms. The most common symptoms reported by respondents were headache (46.9%), tiredness (42.5%), fever (31.9%), and loss of smell and taste sensation (29.0%). The period with the highest number of all the symptomatic respondents as well as those with symptoms suggestive of COVID-19 was between August to October 2020. Correspondingly, 108 (52.17%) symptomatic respondents had a relative with symptoms. Conclusion: The majority of respondents reported having flu-like symptoms in the period from August to October. Moreover, the highest cumulative number of people with suggestive COVID-19 symptoms reported their symptoms in the same period.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.